Literature DB >> 17400667

Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis.

I-Nae Park1, Dong Soon Kim, Tae Sun Shim, Chae-Man Lim, Sang Do Lee, Younsuck Koh, Woo Sung Kim, Won Dong Kim, Se Jin Jang, Thomas V Colby.   

Abstract

BACKGROUND: Acute exacerbation (AE) in idiopathic pulmonary fibrosis (IPF) is increasingly recognized as a relatively common and highly morbid clinical event. However, clinical data on AE in non-IPF interstitial pneumonia are sparse. This study was performed to find the frequency, clinical features, and outcome of AE in non-IPF interstitial pneumonia.
METHODS: Retrospective analysis of 10 patients who satisfied the modified Akira criteria for AE during follow-up of 74 patients with surgical lung biopsy-confirmed idiopathic nonspecific interstitial pneumonia (I-NSIP) and 93 patients with biopsy-confirmed interstitial pneumonia associated with collagen vascular disease (CVD-IP).
RESULTS: AE occurred in six patients with I-NSIP (1-year frequency, 4.2%) and in four patients with CVD-IP (rheumatoid arthritis [RA], n = 3; scleroderma, n = 1), with 1-year frequency of 3.3%. Median age was 58 years (range, 47 to 75); six patients were female. AE occurred in two patients immediately after surgical biopsy. Median duration of acute symptom before hospital admission was 10 days (range, 1 to 30). Median ratio of Pao(2) to the fraction of inspired oxygen (Fio(2)) was 172 (range, 107 to 273), and Pao(2)/Fio(2) ratio was < 200 in six patients. Surgical lung biopsy performed at the time of AE in two patients revealed diffuse alveolar damage superimposed on nonspecific interstitial pneumonia pattern. Four patients with I-NSIP survived to discharge and were followed up for 24 months (range, 6 to 121).
CONCLUSION: AE occurred in the patients with I-NSIP with apparently better prognosis. In patients with CVD-IP, AE occurred mostly with RA-usual interstitial pneumonia in our small series with poor outcome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17400667     DOI: 10.1378/chest.07-0323

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  97 in total

1.  Acute exacerbation of idiopathic interstitial pneumonia after nonpulmonary surgery under general anesthesia: a retrospective study.

Authors:  Kenta Furuya; Susumu Sakamoto; Yujiro Takai; Nobukazu Sato; Keiko Matsumoto; Sakae Homma
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

Review 2.  Management of interstitial lung disease associated with connective tissue disease.

Authors:  Stephen C Mathai; Sonye K Danoff
Journal:  BMJ       Date:  2016-02-24

3.  Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern.

Authors:  Deborah Assayag; Brett M Elicker; Thomas H Urbania; Thomas V Colby; Bo Hyoung Kang; Jay H Ryu; Talmadge E King; Harold R Collard; Dong Soon Kim; Joyce S Lee
Journal:  Radiology       Date:  2013-10-28       Impact factor: 11.105

4.  Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: a prospective study and review of the literature.

Authors:  Andreina Manfredi; Marco Sebastiani; Stefania Cerri; Caterina Vacchi; Roberto Tonelli; Giovanni Della Casa; Giulia Cassone; Amelia Spinella; Pancaldi Fabrizio; Fabrizio Luppi; Carlo Salvarani
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

5.  [Acute on chronic respiratory failure in interstitial pneumonias].

Authors:  M Westhoff
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-08-16       Impact factor: 0.840

6.  Pulmonary function and survival in idiopathic vs secondary usual interstitial pneumonia.

Authors:  Matthew J Strand; David Sprunger; Gregory P Cosgrove; Evans R Fernandez-Perez; Stephen K Frankel; Tristan J Huie; Amy L Olson; Joshua Solomon; Kevin K Brown; Jeffrey J Swigris
Journal:  Chest       Date:  2014-09       Impact factor: 9.410

7.  Circulating fibrocytes as biomarker of prognosis in Hermansky-Pudlak syndrome.

Authors:  Aaron Trimble; Bernadette R Gochuico; Thomas C Markello; Roxanne Fischer; William A Gahl; Jae K Lee; Youngchul Kim; Marie D Burdick; Robert M Strieter; Borna Mehrad
Journal:  Am J Respir Crit Care Med       Date:  2014-12-15       Impact factor: 21.405

Review 8.  Interstitial lung disease in patients with rheumatoid arthritis: spontaneous and drug induced.

Authors:  Robert W Hallowell; Maureen R Horton
Journal:  Drugs       Date:  2014-03       Impact factor: 9.546

9.  Chemotherapy for extensive-stage small-cell lung cancer with idiopathic pulmonary fibrosis.

Authors:  Naohiro Watanabe; Hiroyuki Taniguchi; Yasuhiro Kondoh; Tomoki Kimura; Kensuke Kataoka; Osamu Nishiyama; Masashi Kondo; Yoshinori Hasegawa
Journal:  Int J Clin Oncol       Date:  2013-04-17       Impact factor: 3.402

Review 10.  Intra-thoracic rheumatoid arthritis: Imaging spectrum of typical findings and treatment related complications.

Authors:  Thanissara Chansakul; Paul F Dellaripa; Tracy J Doyle; Rachna Madan
Journal:  Eur J Radiol       Date:  2015-07-17       Impact factor: 3.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.